Credit Suisse’s Array Biopharma Inc ARRY Stock Holding History

Credit Suisse’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-284,400	Closed	-$13.2M	–	4369
2019 Q2	$13.2M	Buy	+284,400	New	+$7.99M	0.01%	1151

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Credit Suisse's ARRY Position: Q3 2019 in Review

Credit Suisse sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,479,960 shares — an estimated $115M sold.

Credit Suisse first reported a position in ARRY in Q2 2013 and held it in 25 quarters. The position peaked at $115M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Credit Suisse reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Credit Suisse sold 2,479,960 Array Biopharma Inc shares in Q3 2019, an estimated $115M.
Credit Suisse first reported a position in Array Biopharma Inc in Q2 2013 and held it in 25 quarters.
Credit Suisse's Array Biopharma Inc position peaked at $115M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.